相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics of Lopinavir in HIV-Infected Adults Receiving Rifampin with Adjusted Doses of Lopinavir-Ritonavir Tablets
Eric H. Decloedt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa
Stephen D. Lawn et al.
AIDS (2009)
Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir
David W. Haas et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets
Hanneke M. J. Nijland et al.
AIDS (2008)
Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis
Yuan Ren et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children
J Ananworanich et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers
CJL la Porte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities
Y Nishimura et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: Potent inhibition of CYP2C19 and CYP3A
Z Desta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
